|
- Bordetella pertussis parapertussis by PCR | ARUP Laboratories Test . . .
New York DOH Approval Status Indicates whether a test has been approved by the New York State Department of Health
- ARUP Laboratories | National Reference Laboratory
ARUP provides reference laboratory testing for hospitals and health centers, serving the diagnostic needs of patients We also consult on lab management, utilization, and operations
- Adrenocorticotropic Hormone | ARUP Laboratories Test Directory
Aids in the diagnosis of adrenal insufficiency and determining the presence of anterior pituitary tumors New York DOH Approval Status Indicates whether a test has been approved by the New York State Department of Health
- About ARUP Laboratories
We are a CAP-, ISO 15189-, and CLIA-certified diagnostic laboratory with more than 40 years of experience supporting hospital and health system clients with unparalleled quality and service Beyond offering quality testing, our goals include innovating, improving continuously, changing the future of laboratory medicine, and supporting our clients’ success in patient care while helping
- ARUP Applauds Federal Court Decision Vacating the FDA’s Final Rule . . .
The company has a robust quality management system and has experience working with the New York Clinical Laboratory Evaluation Program (CLEP) for test approval ARUP made providing education and communication about the final rule a priority and will continue to advocate on behalf of clinical labs
- Testing Specialties - ARUP Laboratories
Testing Specialties This page highlights our testing specialties, test updates, testing resources, compliance statements, and experts
- NEW YORK STATE NON-PERMITTED LABORATORY TEST REQUEST APPROVAL FORM
In these cases, the department’s approval must be received prior to submitting a specimen collected in New York State for testing by a non-permitted laboratory or a permitted laboratory that does not hold approval for that particular test
- The FDAs Final Rule on Laboratory-Developed Tests: FAQs
Under the FDA rule, New York approval still means that, but it also means labs can avoid submitting a test to the FDA for premarket notification or approval It is a faster and much less expensive pathway
|
|
|